Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis

Antimicrob Agents Chemother. 2004 Nov;48(11):4447-9. doi: 10.1128/AAC.48.11.4447-4449.2004.

Abstract

Genetic analysis of the embB gene revealed mutations in 17 (68%) of 25 ethambutol (EMB) resistant isolates (M306I, M306V, M306L, Q497R) but also in 4 (20%) of 20 EMB-susceptible isolates of Mycobacterium tuberculosis, namely, an ATG-->ATM substitution resulting in M306I, G406N, and the novel alterations M423I and A659T.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / pharmacology*
  • Codon / genetics
  • DNA Fingerprinting
  • DNA Primers
  • DNA, Bacterial / genetics
  • Ethambutol / pharmacology*
  • Genes, Bacterial / genetics
  • Microbial Sensitivity Tests
  • Mutation / genetics
  • Mycobacterium tuberculosis / drug effects
  • Mycobacterium tuberculosis / genetics*
  • Polymorphism, Genetic / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Singapore / epidemiology

Substances

  • Antitubercular Agents
  • Codon
  • DNA Primers
  • DNA, Bacterial
  • Ethambutol